Gainers • Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) stock rose 43.93% to $10.50 during Friday’s pre-market session. The most recent rating by HC Wainwright & Co., on Jun 26, is at Buy, with a price target of $12. read more

Read More